Logo image
Se connecter
S201: FINAL 7‐YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX‐RITUXIMAB (VENR)‐TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)
Article de revue

S201: FINAL 7‐YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX‐RITUXIMAB (VENR)‐TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)

Arnon Kater, Rosemary Harrup, Thomas J Kipps, Barbara Eichhorst, Carolyn J Owen, Sarit Assouline, Nicole Lamanna, Tadeusz Robak, Javier de la Serna, Ulrich Jaeger, …
HemaSphere, Vol.7
08/08/2023

Résumé

Biomedical and Clinical Sciences Cancer Cardiovascular Medicine and Haematology Hematology Lymphatic Research Lymphoma Rare Diseases

Indicateurs

1 Consultations de la notice

Détails

Logo image